Skip to main content
رجوع
Watch Compare

Milestone Pharmaceuticals Inc.

جودة البيانات: 83%
MIST
Nasdaq Manufacturing Chemicals
KWD 1.95
▲ KWD 0.17 (9.27%)
القيمة السوقية: 228.86 M
السعر
KWD 1.95
القيمة السوقية
228.86 M
نطاق اليوم
KWD 1.80 — KWD 2.17
نطاق 52 أسبوعًا
KWD 0.69 — KWD 3.06
حجم التداول
10,245,147
فتح KWD 1.80
متوسط 50 يوم / 200 يوم
KWD 1.65
17.88% above
متوسط 50 يوم / 200 يوم
KWD 1.88
3.46% above

Quick Summary

النقاط الرئيسية

Debt/Equity of 2.74 — high leverage
Negative free cash flow of -49.34 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-4576.05%
أقل من متوسط القطاع (-51.02%)
ROIC-85.11%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
2.74
أعلى من متوسط القطاع (0.33)
Current Ratio8.24
Interest Coverage-16.19

التقييم

PE (TTM)
-3.63
أقل من متوسط القطاع (-1.98)
P/B Ratio11.16
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -3.6 -2.0
P/B 11.2 5.1
ROE % -4576.1 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E 2.7 0.3

ETFs Holding This Stock

SURI logo SURI Simplify Propel Opportunities ETF
8.20% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -63.06 M
ROE -4576.05% ROA -93.30%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -49.34 M
ROIC -85.11% FCF Growth (3Y) N/A
Safety
Debt / Equity 2.74 Current Ratio 8.24
Interest Coverage -16.19 Asset Turnover N/A
Working Capital 76.15 M Tangible Book Value 20.50 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3.63 Forward P/E N/A
P/B Ratio 11.16 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -21.56%
Market Cap 228.86 M Enterprise Value 238.38 M
Per Share
EPS (Diluted TTM) -0.75 Revenue / Share N/A
FCF / Share -0.42 OCF / Share -0.42
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 78.25%
SBC-Adj. FCF -54.65 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -63.06 M -41.52 M -59.69 M -58.39 M -42.85 M
EPS (Diluted) -0.75 -0.67 -1.39 — -1.02
Gross Profit — — — — —
Operating Income -62.14 M -42.10 M -61.10 M -59.64 M -43.07 M
EBITDA — — — — —
R&D Expenses 18.11 M 14.36 M 31.05 M 39.83 M 38.67 M
SG&A Expenses — — — — —
D&A 114,000.0 105,000.0 92,000.0 89,000.0 93,000.0
Interest Expense 3.84 M 3.58 M 2.55 M — —
Income Tax — — — — -17,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 113.56 M 75.50 M 75.23 M 74.48 M 119.85 M
Total Liabilities 71.79 M 62.35 M 58.46 M 8.14 M 7.25 M
Shareholders' Equity 41.77 M 13.15 M 16.77 M 66.35 M 112.60 M
Total Debt 57.19 M 53.35 M 49.77 M — —
Cash & Equivalents 73.05 M 25.31 M 13.76 M 7.64 M 114.14 M
Current Assets 111.92 M 73.93 M 73.03 M 71.80 M 118.92 M
Current Liabilities 13.98 M 8.13 M 7.23 M 6.14 M 6.78 M